This content is only available within our institutional offering.

07 Nov 2024
Hikma Pharmaceuticals (HIK LN, 2340p, Buy) (Company Update) - 3Q trading: good momentum, 4% upside to consensus EBIT

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals (HIK LN, 2340p, Buy) (Company Update) - 3Q trading: good momentum, 4% upside to consensus EBIT
Hikma Pharmaceuticals Plc (HIK:LON) | 1,629 -456.1 (-1.7%) | Mkt Cap: 3,615m
- Published:
07 Nov 2024 -
Author:
Miles Dixon | Leolie Telford-Cooke -
Pages:
8 -